Imunon (IMNN) Common Equity (2010 - 2026)
Imunon's Common Equity came in at $3.36 million for Q1 2026, up 643.2% from $452,028 a year earlier but down 52.4% from the prior quarter.
Powered by 
Analysis
Imunon (IMNN) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Imunon's Common Equity was $7.06 million, up 66.4% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -17.6% (FY2020 to FY2025).
- Going back by year, Common Equity was $4.24 million in FY2024 (-68.3%), $13.39 million in FY2023 (-54.4%), $29.33 million in FY2022 (-47.4%) and $55.8 million in FY2021 (+199.8%).
- The five-year range for quarterly Common Equity is $452,028 (Q1 2025) to $64.05 million (Q2 2021).
- Year-over-year, Common Equity increased in two of the last eight quarters, with growth averaging 41.3%.
- The fastest year-over-year change in Common Equity over five years came in Q1 2026 (growth of 643.2%), and the weakest in Q1 2025 (a decline of 94.7%).
- Business Quant data shows IMNN's Common Equity at $7.06 million (Q4 2025), $4.08 million (Q3 2025) and $2.66 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Imunon | 6.44 Mn | 6.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.36 Mn |
| Dec 31, 2025 | 7.06 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 452,028.00 |
| Dec 31, 2024 | 4.24 Mn |
| Sep 30, 2024 | 8.19 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 13.39 Mn |
| Sep 30, 2023 | 18.07 Mn |
| Jun 30, 2023 | 21.52 Mn |
| Mar 31, 2023 | 26.65 Mn |
| Dec 31, 2022 | 29.33 Mn |
| Sep 30, 2022 | 41.35 Mn |
| Jun 30, 2022 | 47.04 Mn |
| Mar 31, 2022 | 46.27 Mn |
| Dec 31, 2021 | 55.80 Mn |
| Sep 30, 2021 | 59.34 Mn |
| Jun 30, 2021 | 64.05 Mn |
API Access
Imunon Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IMNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IMNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IMNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();